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Specific receptor binding of renin on human mesangial cells in
culture increases plasminogen activator inhibitor-i antigen
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Specific receptor binding of renin on human mesangial cells in culture
increases plasminogen activator inhibitor-I antigen. Some proteases
possess a membrane receptor that focalizes their proteolytic activity on the
cell surface and may mediate a proliferative effect, such as urokinase on
glomerular epithelial cells. Since some hypertensive states are associated
with high concentrations of renin and proliferation of arteriolar smooth
muscle cells, we asked whether renin, an aspartyl-protease, would bind to
mesangial cells that are smooth-muscle derived cells, which would induce
their proliferation. The binding of 25j labeled recombinant human renin
(1251-R) was studied on human primary mesangial cells and mesangial cells
immortalized by transfection with SV4O-T antigen. At 37°C, the binding of
'251-R was time dependent and reached a plateau after two hours. 1251-R
was found to bind in a saturable and specific manner with a Kd = 0.4 nM
and 1 nu and 8,000 and 2,000 binding sites/cell, for primary and
immortalized cells, respectively. When binding experiments were per-
formed in the presence RO 42-5892, a synthetic inhibitor of renin, RO
42-5892 could inhibit the specific binding of labeled renin only at
concentrations 1,000 times superior to the IC 50, indicating that the
renin-mesangial receptor interaction did not depend on the active site of
renin. Analysis by SDS-PAGE and autoradiography of cross-linking
experiments of 1251-R bound to a membrane preparation showed a band
of approximately 110 to 120 kDa, suggesting a Mr of 70 to 80 kDa for the
renin receptor. Incubation of mesangial cells with 100 nM renin for 24
hours provoked a 100% increase of 3H thymidine incorporation that was
not accompanied by an increase of the cell number, even after a seven day
period of incubation. However, the incubation of mesangial cells with
renin for 24 hours induced a significant increase (170% of control, P =
0.04) of plasminogen activator inhibitor-I (PAIl) antigen in the condi-
tioned medium. In conclusion, we have shown that human mesangial cells
in culture express a specific receptor for renin, and that the binding of
renin increases 3H thymidine incorporation independently of renin enzy-
matic activity. The absence of cell proliferation, the increase of 3H
thymidine incorporation and the increase of PAIl antigen suggest that the
binding of renin can induce mesangial cell activation, which is reflected
by a change in the fibrinolytic capacity of the cells. The role of this
receptor remains to be determined in nephropathies and hypertensive
states associated with high plasma/tissue renin concentrations, hypertro-
phy of mesangial or smooth muscle cells and extracellular matrix remod-
eling.
Renin is synthetized by juxtaglonierular cells and, to a lesser
extent by mesangial cells, in humans [1] and in rats [2]. The
primary function of this aspartyl-protease is to activate angio-
tensinogen in angiotensin I by limited proteolysis, thereby con-
trolling the limiting step of the angiotensin II formation. Angio-
tensin I is then converted into angiotensin II by the angiotensin
converting enzyme. Evidence for a tissue production of angioten-
sin II is accumulating. This tissue generation of angiotensin may
result from either the local synthesis of renin and angiotensinogen
[reviewed in 3], or from the uptake of both proteins from plasma
as for the vascular tissue [4, 5]. Recently, Campbell and Valentijn,
looking for a renin-binding mechanism responsible for the tissue
uptake of renin from plasma, have described two renin-binding
proteins [6]. They identified these renin-binding proteins in
membranes prepared from rat mesenteric arteries and rat
smooth-muscle cells in culture, but also in several tissues. Surpris-
ingly, they did not find these vascular renin-binding proteins in the
kidney cortex. Since glomerular mesangial cells are smooth-
muscle derived cells [7], we decided to examine the existence of a
cell surface renin-binding protein in human mesangial cells in
culture. Our results show the existence of a specific receptor of
renin on human mesangial cells. This receptor is of high affinity
(Kd = 0.4 nM) and of limited number on the cell surface (8,000
sites/cell). The binding of renin increases 3H thymidine incorpo-
ration by human mesangial cells in culture, which was not
associated with an increase in the cell number but with an increase
of plasminogen activator inhibitor-i (PAIl) antigen.
Methods
Reagents
1251 was from ICN Pharmaceuticals Inc. (Costa Mesa, CA,
USA). Recombinant human renin and RO 42-5892 [81, an inhib-
itor of renin, were a kind gift from Dr. Walter Fischli (F.
Hoffmann-La Roche LTD, Basel, Switzerland). Renin was labeled
using the IODO-GEN method [9], to specific activities of 0.75
jsCi/pmol. Phenylmethanesulfonyl fluoride (PMSF) was obtained
from Sigma Chemical Co. (St. Louis, MO, USA), and disuccin-
imidyl suberate was from Pierce Chemical Co (Rockford, IL,
USA). RPMI 1640, fetal calf serum (FCS), penicillin and strep-
tomycin were from Gibco Laboratories (Grand Island, NY, USA).
L-glutamin was supplied by Sigma Chemical Co.
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Glomeruli isolation and cell culture
Human kidney cortex was obtained from kidney unsuitable for
transplantation and the glomeruli were isolated by sequential
sieving as described [10]. The glomeruli were stored in RPMI
1897
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1640 at —30°C. Primary culture of human mesangial cells (MC)
was established and characterized as reported [11]. The cells were
cultured in RPMI 1640 supplemented with 10% FCS and con-
taining 2 mr'i L-glutamine, 10 g/ml penicillin and 100 ig/m1
streptomycin, and used at passes 3 and 4. One cell line (C2M12)
derived from mesangial cells by transfection with a plasmid
containing SV40-large T antigen was established and character-
ized as reported [121. These cells were used between passes 60 to
80.
Membrane preparation
A membrane preparation from C2M12 cells was made as
described [131. Briefly, the cells were rapidly washed thrice with
cold Krebs-Henseleit buffer (Krebs: 118 mM NaCl, 5 mvt KCI, 1.1
mM MgSO, 2,5 mrvi CaCl2, 1.2 mMKH2PO4, 25 mrvi NaHCO3, pH
7.4), and scrapped in the homogenization buffer (5 mM Tris-HC1,
pH 7.4, containing 0.25 M sucrose, 500 units/mi of Trasylol, 1 mM
EGTA and 1 m'vi PMSF). The cells were homogenized at 0°C in
a Teflon Potter homogenizer. Two milliliters of the homogenate
were loaded on 1 ml of Tris-HC1 20 mrvi, pH 7.5 containing 1.45 M
sucrose. After centrifugation for 30 minutes at 35,000 X g, the
membranes at the interface were collected, pelleted for 20
minutes at 40,000 x g, and washed two times in 10 mM HEPES,
pH 7.5, containing 0.2 mt CaCl2, 5 mvt MgC12, 250 units/mi
Trasylol and 0.5 mt PMSF. The protein content was determined
by the method of Peterson [14J and the membranes were stored at
—30°C.
Binding assays
The binding studies were performed on glomeruli, on intact
cells and on C2M12 membranes. Binding experiments to intact
cells were done on cells grown on 24-well culture plates. Prior to
the binding studies, glomeruli, mesangial cells or C2M12 cells were
treated with acid buffer [151 in order to remove potential endog-
enously bound renin. For time course experiments, the cells were
incubated with 50,000 cpm 1251-R (50 pM) diluted in 100 j.d Krebs
buffer containing 2% bovine serum albumin (K-BSA), with or
without I j.M cold renin to measure the nonspecific binding. At
intervals, the supernatant was withdrawn for analysis by SDS
polyacrylamide gel and autoradiography, and for treatment with
trichloracetic acid (TCA) 10% final concentration in order to
analyze the extent of the degradation of renin, which would
appear as an increase in the TCA soluble fraction. To study the
reversibility of the binding of renin to the membranes, the
membranes were allowed to bind labeled renin for two hours at
37°C, then 1 1LM cold renin was added and the incubation
prolonged for four hours. After two washes with Krebs buffer,
membrane associated radioactivity was determined at intervals.
For saturation studies, the cells were incubated for two hours at
37°C with increasing amounts of '251-R (25 M to 5 flM) and the
nonspecific binding determined in the presence of 1 jLM renin. The
supernatant was discarded, the cells were washed twice with I ml
Krebs, solubilized with 1 ml NaOH I M, and the cell associated
radioactivity was counted. Binding to isolated cell membranes was
studied at 37°C, incubation being carried out in Eppendorf tubes
for two hours with '251-R from 5 M to 5 nM. The membranes were
then centrifuged (3 mm at 10,000 X g in a microcentrifuge),
washed twice with 1 ml Krebs, and membrane-associated radio-
activity counted. To study the effects of RO 42-5892, a synthetic
inhibitor of renin enzymatic activity, on the binding of labeled
renin to isolated membranes, RU 42-5892 was diluted in DMSO
and added to final concentrations from 1 M to 10 tM.
3H thymidine incorporation and proliferation studies
Primary mesangial cells were grown to subconfluency in 24-well
culture plates, and serum starved for 24 hours before the addition
of increasing concentrations of renin (0 to 200 nM) diluted in
RPMI without serum. After 18 hours of incubation, 1 Ci 3H
thymidine was added, and the cells were further incubated for six
hours. At the end of the incubation time, the supernatant was
discarded, the cells were detached with trypsin and counted, and
cell incorporated radioactivity counted in a f3 counter. The
proliferation of mesangial cells was studied in the presence of 100
nM renin or 10% FCS as a control, over a seven day period and
with fresh medium replaced every two days.
PAIl antigen was measured by ELISA [16] as described.
Cross-linking of labeled renin to isolated cell membranes
Twenty micrograms of membranes were incubated with 106
cpm 1251-R (200 fmol), washed twice with 1 ml Krebs, and
cross-linked with DSS 1 mM in DMSO for 30 minutes at room
temperature. The reaction was stopped by addition of electro-
phoresis sample buffer and boiled for three minutes. Proteins
were analyzed by electrophoresis on a 7.5% SDS-polyacrylamide
gel [17], and the gels dried before exposure to X-ray films.
Statistical analyses
The effects of renin on 3H thymidine incorporation and on
PAIl secretion by mesangial cells were compared using Student's
t-test for paired values.
Results
Binding of ['251-R] to glomeruli, mesangial cells and C2M12
membranes
The kinetics of binding of 1251-R to the cells and to the
membranes at 37°C were similar. As shown in Figure 1 with
mesangial cells membranes, the binding increased with time,
reached a plateau by 120 minutes and remained constant for at
least four hours, indicating that '251-R associates with the mem-
brane-binding protein in a time-dependent manner. The binding
of renin was very slowly reversible, and 50% of 1251-R was
dissociated after four hours (Fig. 1). When the binding of 1251-R
was studied in the presence of intact cells, no increase of the
trichioracetic acid-soluble radioactivity could be evidenced in the
cell supernatant (data not shown), indicating that cell-associated
radioactivity was not degraded after four hours of incubation.
Furthermore, analysis by SDS-PAGE and autoradiography of the
labeled renin incubated with mesangial cells up to 48 hours
showed no radioactive material of lower molecular weight than
1251-R, confirming that the renin bound to the receptor was not
degraded over a 48 hour period (Fig. 2). The nonspecific binding
was studied in the presence of 1 M cold renin and represented
approximately 60% of the total binding on glomeruli, and mes-
angial cells, and 40% on C2M12 membranes (Table 1). In addition,
the presence of excess of two nonrelated proteases, thrombin and
tissue-type piasminogen activator (tPA) did not affect '251-R
binding on C2M12 membranes (Table 1).
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Fig. 1. Time dependency and reversibility of saturable binding of '251-R to
C2M12 membranes. Ten microgram membranes in Eppendorf tubes were
incubated at 37°C with 50,000 cpm 1251-R (50 pM) and the nonspecific
binding was determined in the presence of I M renin. At intervals, the
membranes were centrifuged in a microfuge, washed twice with 1 ml Krebs
buffer, and membrane-associated radioactivity counted. To study the
reversibility of renin binding, after 251-R binding has reached the plateau,
1 tLM cold renin was added to the incubation medium. The dissociation of
1251R bound to its receptor in the presence of cold renin was measured
during four hours. Each point represents the specific binding (total 1251-R
bound 15I-R bound in the presence of I rM cold renin) and is the
average of two determinations.
Saturation of binding
To determine the dissociation constant and the number of
binding sites, increasing concentrations of 1251-R were incubated
with either mesangial cells or C2M12 membranes for two hours at
37°C, in the presence or absence of 1 fLM unlabeled renin.
Scatchard analysis from both specific binding data showed the
existence of one high affinity binding site with an apparent Kd =
0.4 nM and 1 nM for mesangial cells and C2M12 membranes,
respectively, and Bmx = 8.000 sites/cell for mesangial cells and 12
M for 10 .tg membranes, corresponding to approximately 2,000
sites/C2M12 cell (Fig. 3), Additional studies were made where
mixtures of labeled (50 pM) and unlabeled renin (0 to 1000 nM)
were incubated for two hours with the C2M12 membranes, and
membrane-associated radioactivity was measured as described. A
dissociation constant of 1.5 nM was obtained (Fig. 4). The binding
of labeled renin on glomeruli was also investigated. Even though
was able to bind to glomeruli, and the binding could be
decreased by 40% in the presence of 1 M cold renin, the
saturation of binding studies and the Scatchard transformation
failed to show the presence of the high affinity binding site on
glomeruli (data not shown). The binding of labeled renin was also
studied in the presence of RO 42-5892, a potent synthetic
inhibitor of renin enzymatic activity. In vitro, the inhibition of the
enzymatic activity of purified human renin by RO 42-5892 was
characterized by an IC 50 of 0.7 nM [81. In contrast, inhibition of
the binding of labeled renin to mesangial cells membranes
became significant with 100 nM RO-42-5892, and a complete
Fig. 2. Molecular forms of renin incubated with mesangial cells. Mesangial
cells were incubated with 100 M 251-R for up to 48 hours, in RMPI
without serum, and the molecular forms of labeled renin in the condition
medium were analyzed on a 14% SDS-PAGE and autoradiography. Lane
A, 251-R alone; lane B, 251-R incubated with MC for 24 hours; lane C,
251-R incubated with MC for 48 hours. The molecular weight markers are
on the left.
Table 1. Inhibition of binding of 25I-labeled renin to human glomeruli,
mesangial cells and C2M12 membranes by 1 tM cold renin, thrombin
and tissue plasminogen activator
Competitor None
Renin Thrombin tPA
Ii
Glomeruli 100 66 9 ND ND
Mesangial cells 100 56 12 ND ND
C2M12 membranes 100 40 14 109 127
ND is not done.
Approximately 30 glomeruli (100 j.rg of protein), 50,000 mesangial cells
(MC) in a 24 well plate, or 10 g of C2M12 membranes were incubated for
2 hours with 50 M 1251-R, in the presence or the absence of I !LM renin.
C2M12 membranes were also incubated with excess of nonrelevant pro-
teases, thrombin and tissue plasminogen activator (tPA). The results are
expressed as % of the radioactivity bound in the absence of cold renin. The
data represent the mean or mean SD of 2 experiments performed in
duplicate (except for thrombin and tPA where the experiments werc
performed only once in duplicate).
inhibition of specific binding was observed only with 1 /.LM RO
42-5 892 (Fig. 4). These results indicate that the binding of renin to
mesangial cell binding-protein is not dependent on the presence
of the active site of renin.
Thymidine incorporation and proliferation
When primary mesangial cells were stimulated with renin for 18
hours, there was a dose dependent increase in thymidine incor-
poration. The increase was already significant with 16 nM, and
there was a 100% increase in 3H thymidine incorporation in the
presence of 100 n (Fig. 5). The mitogenic effect of renin was not
associated with a proliferative effect, since stimulation of mesan-
gial cells with 100 nM renin over a seven day period did not change
1 l.tM renin
+
Nguyen et al: Renin receptor binding and PAIl secretion 1899
kDa A B C
97 —
66 —
45 —
31 —
21 —
14 —
0 60 120 180 240 300 360 420
0
-oC
0
Renin, fmol Renin, fmol
Fig. 3. Equilibrium binding of '251-R to mesangial cells and to C2M12 membranes at 37°C isotherm. Mesangial cells in 24 well-plate (Fig. 1A) and C2M12
membranes (Fig. IB) in Eppendorf tubes were incubated with increasing concentrations of 251-R, with or without 1 /LM cold renin, for two hours at
37°C. The specific binding was determined by substracting cell-associated radioactivity in the presence of cold renin. Inset. Scatchard transformation
of the data. The results showed a Kd = 400 M and 8,000 sites/cell for mesangial cells, and K = I nM and Bmu. = 12.5 pM/I0 rg membrane
(approximately 2,000 sites/C2M12 cell).
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Fig. 4. Effect of cold renin and of RO 42-5892 on the binding of labeled renin
to C,M12 membranes. Ten microgram membranes were incubated with
25,000 cpm 1251-R (15 pM), either with increasing concentrations (10 M to
1 /.LM) of cold renin (•), orwith increasing concentrations (I M to 10 /.LM)
of RU 42-5892 (U) for two hours at 37°C. After centrifugation at 10,000 g,
the membranes were washed twice with I ml Krebs buffer, and membrane-
associated radioactivity counted. The results are expressed as specific
binding, and represent the mean of two separate experiments made in
duplicate.
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the cell number as compared to control and in contrast to cells
stimulated with 10% fetal calf serum (not shown).
PAIl antigen assay
The effect of renin on the secretion of PAIl was studied by
measuring PAIl antigen in the conditioned medium of mesangial
cells stimulated for 18 hours by renin. The results showed that
incubation of refill with mesangial cells increased in a dose
dependent manner PAIl antigen. The increase of PAIl attained
130% and 180% with 100 nM and I /tM renin, respectively, as
compared to PAIl in the supernatants of nonstimulated cells
(Fig. 6).
Cross-linking of renin to its receptor
To estimate the size of the renin-binding protein on immortal-
ized mesangial cells membranes, '251-R was incubated with the
membranes and cross-linked using disuccinimidyl suberate. In
addition to the band of 40 kDa representing free labeled renin,
one band of 110 to 120 kDa was observed (Fig. 7). This band
completely disappeared in the presence of excess of unlabeled
renin. These results suggest that the binding of renin is mediated
by a protein of approximately 70 to 80 kDa.
Discussion
This study is the first report of a functional cell surface receptor
of renin on human mesangial cells that are smooth muscle-derived
cells. Renin binds to mesangial cells in culture via a high affinity
membrane receptor, and the binding of renin increases 3H
thymidine incorporation by mesangial cells in vitro. Apart from
this mesangial cell receptor, other renin-binding proteins have
been reported in the literature. One binding protein known as
renin-binding protein (RnBP) has been characterized and cloned
from porcine [181 and rat kidney [19], and from human Wilm's
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Fig. 5. 3H thymidine incorporation by mesangial cells stimulated with renin.
A total of 50,000 cells in a 24 well-plate were incubated with RPMI alone
(control) or with RPMI containing increasing concentrations of renin (16
to 200 nM) for 18 hours before addition of 1 pCi 3H thymidine. The
incubation was prolonged six hours, the cells washed twice with RPMI,
and cell-associated radioactivity counted in a f3 counter. The results are
expressed as % of control, and represent the mean SD of 4 independent
experiments performed in duplicate. J3 < 0.05 compared to control.
Fig. 6. Effect of renin on PAIl secretion by human mesangial cells. Mesan-
gial cells in a 24-well plate were incubated with increasing concentrations
of renin for 24 hours at 37°C and PAIl antigen was measured in the
conditioned media by ELISA. Lane A, control; lane B, renin 10 n; lane
C, renin 100 nM; lane D, renin 1 !LM. The results are expressed as % of
control and represent the mean SD of 4 independent experiments
performed in duplicate. *p < 0.04 compared to control.
tumor cells as well [191. This RnBP characterized by a leucine
zipper motif and the absence of a signal sequence, has a Mr of 42
kDa and binds renin to form an inactive complex called "high
molecular weight renin" with a dissociation constant of 0.2 nM.
The role of RnBP would be to modulate the release of active
Fig. 7. Cross-linking of '251-labeled renin to C2M,2 membranes. A total of
1,000,000 cpm 1251-R (200 fmol) were incubated with 20 jsg membranes
for at 37°C, washed, and 25I-R bound to the membranes was cross-linked
to the membrane-binding protein with DSS 1 mrvi, 30 minutes at room
temperature. The reaction was stopped by the addition of the electro-
phoresis buffer, the proteins were separated on a 7.5% SDS-PAGE under
reducing conditions, and the gel subjected to autoradiography. Lane 1,
'25I-R alone; 2, '251-R incubated with DSS 1 mi, 30 minutes at room
temperature; 3, 1251-R incubated with membranes; 4, '251-R incubated
with membranes in the presence of I M cold renin. The molecular weight
markers are indicated on the left side.
renin in renin-producing cells [20]. Although the RnBP has been
well characterized at the molecular level, no immunologic studies
of cell and tissue distribution have been made. Recently, two
other renin-binding proteins have also been described on mem-
branes from rat mesenteric artery and rat aortic smooth muscle
cells in culture [6]. This study was based on the cross-linking of
labeled rat renin to the crude membrane preparations. The
autoradiographs of rat 1251-R cross-linked to membranes prepa-
rations showed the existence of two complexes of Mr 75 and 105
kDa in addition to the band of free renin at 34 kDa, suggesting
that rat renin was complexed to membranes proteins of 40 and 70
kDa. The lack of rat renin has precluded the characterization of
the binding parameters. However, the very high concentration (2
1LLM) of cold renin necessary to inhibit 50% of binding to both
binding proteins, suggested low affinity binding sites, with a Kd in
the /.LM range, and a very high capacity of binding. These results
are different from those obtained with mesangial cells, in which we
observed a Kid in the nM range and a limited number of binding
sites per cell. In addition, the binding of rat renin to mesenteric
artery membranes appeared to be mediated by the active site,
which is in contrast with our results.
The incubation of mesangial cells with renin increased 3H
thymidine incorporation but was not associated with cell prolifer-
ation, as already reported when mesangial cells were stimulated
either by urokinase [11] or thrombin [16]. A similar situation
could also be observed in vivo in vascular smooth muscle cells of
chronic hypertensive animals [21]. In these animals, the growth
response of smooth muscle cells was dependent on the nature of
the model and resulted from the association of different degrees
of hypertrophy and of hyperplasia. The hypertrophy was often but
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not necessarily accompanied by a polyploidy, which was reflected
an adaptative cellular growth. Since mesangial cells are smooth
muscle-derived cells, this could well fit our observation and could
explain the apparent discrepancy between the increase of 3H
thymidine incorporation, the absence of proliferation and the
increase of PAIl antigen in mesangial cells stimulated by renin.
One could question whether or not the increase of 3H thymi-
dine incorporation by mesangial cells in the presence of renin
could be attributed to the generation of angiotensin II. Indeed, it
has been shown recently that angiotensin II has important non-
hemodynamic effects, such as the stimulation of plasminogen
activator inhibitor type-I in vivo [22] and in vitro [23, 24],
providing a link between the renin-angiotensin system and throm-
botic risks. Angiotensin II also has an hypertrophic effect and
stimulates collagen synthesis in human adult mesangial cells [251.
Since mesangial cells do not synthesize angiotensinogen (F. Pinet,
personal communication; PCR analysis for angiotensinogen
mRNA was negative in primary mesangial cells and in C2M12
immortalized mesangial cells) and that they do not have convert-
ing enzyme activity [26], it is unlikely that the mitogenic effect of
renin could be due to angiotensin II.
All together, our results clearly demonstrate that the renin
receptor on mesangial cell is different from the vascular renin-
binding protein in rats and from the RnBP: (1) The dissociation
constant is 400 M compared to the J.LM range in rat mesenteric
artery and rat smooth muscle cells membranes [6]. (2) The
mesangial receptor was characterized on cells cultured from
glomeruli whereas the vascular renin-binding protein could not be
evidenced in the kidney cortex [6]. (3) In contrast to findings on
rat mesenteric artery membranes [6], inhibition of renin active site
does not influence the binding of labeled renin to mesangial cells
membranes, indicating that the hypertrophic effects of renin are
dissociated from renin proteolytic activity. (4) The Mr of the
mesangial receptor was 70 kDa compared to 42 kDa for RnBP
[18].
The importance of the renin-angiotensin system in hyperten-
sion and in the progression of renal diseases is well established,
and further supported by recent models of in vivo transfer in rats
of the human genes of renin [27], and of renin and angiotensino-
gen [28]. Furthermore, the recent work of Niimura et al [29]
emphasizes the importance of renin biological activity. These
authors have produced homozygous mice with a null mutation in
the angiotensinogen gene. Although the animals were hypoten-
sive, they had increased renin expression and they developed
severe lesions in the renal cortex at three weeks of age, charac-
terized by mesangial expansion near the vascular pole and medial
hyperplasia of the interlobular arteries and afferent arterioles,
resembling those of hypertensive nephrosclerosis. The authors
suggested that elevated renin may be linked to the cell prolifera-
tion via the generation of an unknown substrate different from
angiotensinogen. Our results suggest that renin per se could he
important in smooth muscle cell hypertrophy and/or hyperplasia.
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